Clinical Trial Update: Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and preliminary activity of combining sunitinib with gemcitabine in pancreatic cancer and other solid tumors; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer
• Solid Tumors

Drugs mentioned

• Gemzar (gemcitabine)
• Sutent (sunitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer | Phase 1 | Status: COMPLETED